Ethyl Chloride as an Antipruritic Agent: A Double-Blind Placebo-Controlled Prospective Study

Background: Ethyl chloride (EC) is usually used as a topical anesthetic spray agent. However, its antipruritic effects have never been studied, to the best of our knowledge. Methods: A double-blind placebo-controlled prospective study. Overall, 51 healthy volunteers underwent a histamine skin prick test on both arms in order to trigger local pruritus. Thereafter, the affected areas were treated with an EC spray on one arm and a saline spray (placebo) on the other. Subjects as well as researchers were blind to which sprays were used. Subjects reported improvement in pruritus following EC/placebo and rated the intensity of pruritus by using a validated questionnaire and a visual analog scale. The flare and wheal reactions were measured in both arms before and following treatment with EC/placebo. Results: Significant improvement in pruritus was reported more frequently following treatment with EC compared with placebo (84 vs. 16%; p < 0.0001). Significant reduction in pruritus intensity was reported immediately and 15 min following treatment with EC compared with placebo (p < 0.05). There was no significant difference between EC and placebo in terms of the flare and wheal reactions. Conclusions: EC is an effective antipruritic agent, and it does not change the wheal and flare reactions, making it ideal for treating pruritus secondary to allergy skin tests without masking their results.

[1]  Alexandru D. P. Papoiu,et al.  What causes itch in atopic dermatitis? , 2008, Current allergy and asthma reports.

[2]  A. Souéid,et al.  Ethyl Chloride as a Cryoanalgesic in Pediatrics for Venipuncture , 2007, Pediatric emergency care.

[3]  E. Davies,et al.  Comparison of ethyl chloride spray with topical anaesthetic in children experiencing venepuncture. , 2006, Paediatric nursing.

[4]  K. Waibel,et al.  Effect of topical vapocoolant spray on skin test wheal, flare, and pain responses. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  M. Schmelz,et al.  Itch--mediators and mechanisms. , 2002, Journal of dermatological science.

[6]  G. Yosipovitch,et al.  A questionnaire for the assessment of pruritus: validation in uremic patients. , 2001, Acta dermato-venereologica.

[7]  B. Bromm,et al.  Cortex areas involved in the processing of normal and altered pain. , 2000, Progress in brain research.

[8]  K. Mizumura,et al.  Potentiation and suppression of the histamine response by raising and lowering the temperature in canine visceral polymodal receptors in vitro , 1999, Neuroscience Letters.

[9]  R. Jacobson,et al.  Taking the sting out of shots: control of vaccination-associated pain and adverse reactions. , 1998, Pediatric annals.

[10]  Hermann O. Handwerker,et al.  Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.

[11]  D. Silverberg,et al.  Randomised crossover trial of naltrexone in uraemic pruritus , 1996, The Lancet.

[12]  M. Greaves,et al.  Pathophysiology of itching , 1996, The Lancet.

[13]  S. McMahon,et al.  Itching for an explanation , 1992, Trends in Neurosciences.

[14]  R. Marks,et al.  Relief of experimentally induced pruritus with a novel eutectic mixture of local anaesthetic agents , 1988, The British journal of dermatology.